MoneyWorks4Me

Dr Lal Pathlabs informs about disclosure

21 Nov 2019 Evaluate

Dr Lal Pathlabs has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for (Hony) Brig. Dr. Arvind Lal.

The above information is a part of company’s filings submitted to BSE.

Peers